Naturally Occurring Antibodies to Epithelial Cell Adhesion Molecule (EpCAM)

Digestive Diseases and Sciences

Volumn 48, Issue 12, 2003, Pages 2306-2309

  Kirman, Irena ^a,b   Jenkins, Dareema ^a   Fowler, Ryan ^a   Whelan, Richard L ^a  

^a Department of Surgery ^*  (United States)

^b BB1716 ^*  (United States)

Author keywords

Adhesion molecules; Antibody formation; Antigens; Colonic neoplasm

Indexed keywords

ANTIGEN; CELL ADHESION MOLECULE; CELL PROTEIN; EPITHELIAL CELL ADHESION MOLECULE; EPITHELIAL CELL ADHESION MOLECULE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CANCER PATIENT; CELL STRAIN HT29; COLON CANCER; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, CD3; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED;

EID: 0347694786     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000007867.25896.ce     Document Type: Article

References (19)

1. Herlyn M, Steplewski Z, Herlyn D, Koprowski H: Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 76:1438-1452, 1979
2. Balzar M, Winter MJ, de Boer CJ, Litvinov SV: The biology of the 17-1A antigen (Ep-CAM). Review. J Mol Med 77:699-712, 1999
3. Birebent B, Somasundaram R, Purev E, Li W, Mitchell E, Hoey D, Bloom E, Mastrangelo M, Maguire H, Harris DT, Staib L, Braumuller H, Leeser C, Kuttner N, Beger HG, Herlyn D: Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients. Crit Rev Oncol Hematol 39:107-113, 2001
4. Mellstedt H, Fagerberg J, Frodin JE, Hjelm-Skog AL, Liljefors M, Markovic K, Mosolits S, Ragnhammar P: Ga733/EpCAM as a target for passive and active specific immunotherapy in patients withcolorectal carcinoma. Ann NY Acad Sci 910:254-261, 2000
5. Maruyama H, Zaloudik J, Li W, Sperlagh M, Koido T, Somasundaram R, Scheck S, Prewett M, Herlyn D: Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine. Cancer Immunol Immunother 49:123-132, 2000
6. Staib L, Birebent B, Somasundaram R, Purev E, Braumuller H, Leeser C, Kuttner N, Li W, Zhu D, Diao J, Wunner W, Speicher D, Beger HG, Song H, Herlyn D: Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients. Int J Cancer 92:79-87, 2001
7. Albanopoulos K, Armakolas A, Konstadoulakis MM, Leandros E, Tsiobanou E, Katsaragakis S, Alexiou D, Androulakis G: Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer. Am J Gastroenterol 95:1056-1061, 2000
8. Haidopoulos D, Konstadoulakis MM, Antonakis PT, Alexiou DG, Manouras AM, Katsaragakis SM, Androulakis GF: Circulating anti-CEA antibodies in the sera of patients with breast cancer. Eur J Surg Oncol 26:742-746, 2000
9. Hamanaka Y, Suehiro Y, Fukui M, Shikichi K, Imai K, Hinoda Y: Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer. Int J Cancer 103:97-100, 2003
10. Syrigos KN, Charalampopoulos A, Pliarchopoulou K, Syrigou EI, Avuzuklidou M, Manouras A, Leandros M: Prognostic significance of autoantibodies against tropomyosin in patients with colorectal adenocarcinoma. Hybridoma 18:543-546, 1999
11. Green JA, Mudenda B, Jenkins J, Leinster SJ, Tarunina M, Green B, Robertson L: Serum p53 auto-antibodies: incidence in familial breast cancer. Eur J Cancer 30A:580-584, 1994
12. Lenner P, Wiklund F, Emdin SO, Arnerlov C, Eklund C, Hallmans G, Zentgraf H, Dillner J: Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study. Br J Cancer 79:927-932, 1999
13. Mosolits S, Harmenberg U, Ruden U, Öhman L, Nilsson B, Wahren B, Fagerberg J, Mellstedt H: Autoantibodies against the tumor-associated antigen GA733-2 in patients with colorectal carcinoma. Cancer Immunol Immunother 47:315-320, 1999
14. Riethmuller G, Holz E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Funke I, Pichlmaier H, Hirche H, Buggisch P, Witte J, Pichlmayr R: Monoclonal antibody therapy for resected Dukes' C colerectal cancer: Seven-year outcome of a multicenter randomized trial. J Clin Oncol 16:1788-1794, 1998
15. Punt CJ, Nagy A, Douillard JY, Figer A, Skovsgaard T, Monson J, Barone C, Fountzilas G, Riess H, Moylan E, Jones D, Dethling J, Colman J, Coward L, MacGregor S: Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage 111 colon cancer: a randomised study. Lancet 360:671-677, 2002
16. 125I-antibody therapy efficacy in multicell spheroids. Cancer Res 52:4728-4734, 1992
17. Velders MP, van Rhijn CM, Briaire IH, Fleuren GJ, Warnaar SO, Litvinov SV: Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in nude mouse xenograft carcinoma model. Cancer Res 55:4398-4303, 1995
18. Scanlan MJ, Welt S, Gordon CM, Chen YT, Gure AO, Stockert E, Jungbluth AA, Ritter G, Jager D, Jager E, Knuth A, Old LJ: Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res 62:4041-4047, 2002
19. Basak S, Eck S, Gutzmer R, Smith AJ, Birebent B, Purev E, Staib L, Somasundaram R, Zaloudik J, Li W, Jacob L, Mitchell E, Speicher D, Herlyn D: Colorectal cancer vaccines: antiidiotypic antibody, recombinant protein, and viral vector. Ann NY Acad Sci. 910:237-252, 2000